QT Imaging Holdings

QT Imaging Holdings

QT Imaging Holdings operates as a publicly traded medical technology company focused on advancing women's health diagnostics. The firm's core asset is the QTscan, a breast imaging device cleared by the U.S. Food and Drug Administration. The technology employs transmission ultrasound to generate three-dimensional images of breast tissue, avoiding the radiation exposure of mammograms and the discomfort of standard breast compression. The company transitioned to the public markets via a de-SPAC merger with GigCapital5 in March 2023, listing on the Nasdaq under the ticker QTI. The QTscan system is positioned as an adjunct to conventional mammography rather than a direct replacement, particularly useful for patients with dense breast tissue where traditional X-ray imaging is less effective. The device captures over 10 million data points per scan and reconstructs the data into a high-resolution volumetric image that reflects tissue properties like sound speed and attenuation. Distribution strategy involves both direct sales to imaging centers and licensing agreements. In March 2024, QT Imaging signed a strategic distribution agreement with a major teleradiology provider to expand clinical access across multiple U.S. states. The firm operates from its headquarters in Novato, California, where it maintains its R&D and manufacturing operations. Following the 2023 public listing, the executive team includes Dr. John Klock, a physician and former biotechnology executive, who serves as Chief Medical Officer. The company's workforce size is not publicly disclosed. The board features directors associated with the GigCapital SPAC sponsor group, which remains a significant legacy influence on governance. QT Imaging's structural differentiator lies in its fully non-invasive physics engine. By estimating sound-speed maps of breast tissue rather than using radiation-based attenuation, the QTscan collects quantitative acoustic data that is inherently operator-independent and repeatable. This creates a distinct data architecture: unlike standard ultrasound which depends heavily on technician skill, the QTscan generates a standardized dataset suitable for integration with machine-learning diagnostic classifiers and remote tele-radiology workflows.